Last updated on February 2018

ADVATE Hemophilia A Outcome Database (AHEAD)

Brief description of study

The purpose of the study is to document the natural history of hemophilia. A disease and long-term outcomes in terms of effectiveness, safety and quality of life (QoL) in participants receiving ADVATE in routine clinical practice. Participants may use any treatment regimen, including on-demand and prophylaxis using standardized regimens or individual pharmacokinetic (PK)-guided dosing regimens, or immune tolerance induction (ITI) therapy, as determined by the treating physician.

Clinical Study Identifier: NCT02078427

Contact Investigators or Research Sites near you

Start Over

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.